292 related articles for article (PubMed ID: 19371742)
1. Blockade of adrenoreceptors inhibits the splenic response to stroke.
Ajmo CT; Collier LA; Leonardo CC; Hall AA; Green SM; Womble TA; Cuevas J; Willing AE; Pennypacker KR
Exp Neurol; 2009 Jul; 218(1):47-55. PubMed ID: 19371742
[TBL] [Abstract][Full Text] [Related]
2. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke.
Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X
J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548
[TBL] [Abstract][Full Text] [Related]
3. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.
Savitz SI; Erhardt JA; Anthony JV; Gupta G; Li X; Barone FC; Rosenbaum DM
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1197-204. PubMed ID: 10950380
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
5. Cord blood rescues stroke-induced changes in splenocyte phenotype and function.
Vendrame M; Gemma C; Pennypacker KR; Bickford PC; Davis Sanberg C; Sanberg PR; Willing AE
Exp Neurol; 2006 May; 199(1):191-200. PubMed ID: 16713598
[TBL] [Abstract][Full Text] [Related]
6. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
Smith EF; Slivjak MJ; Gagnon R
Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
[TBL] [Abstract][Full Text] [Related]
7. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Yaoita H; Sakabe A; Maehara K; Maruyama Y
Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928
[TBL] [Abstract][Full Text] [Related]
8. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.
Nieminen T; Ylitalo R; Kööbi T; Ylitalo P; Kähönen M
Arzneimittelforschung; 2005; 55(4):205-11. PubMed ID: 15901043
[TBL] [Abstract][Full Text] [Related]
9. Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
de Mey C; Breithaupt K; Schloos J; Neugebauer G; Palm D; Belz GG
Clin Pharmacol Ther; 1994 Mar; 55(3):329-37. PubMed ID: 7908256
[TBL] [Abstract][Full Text] [Related]
10. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.
Batenburg WW; van Esch JH; Garrelds IM; Jorde U; Lamers JM; Dekkers DH; Walther T; Kellett E; Milligan G; van Kats JP; Danser AH
J Hypertens; 2006 Jul; 24(7):1355-63. PubMed ID: 16794485
[TBL] [Abstract][Full Text] [Related]
12. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor modulates the peripheral immune response in a rat model of emergent large vessel occlusion.
Davis SM; Collier LA; Winford ED; Leonardo CC; Ajmo CT; Foran EA; Kopper TJ; Gensel JC; Pennypacker KR
J Neuroinflammation; 2018 Oct; 15(1):288. PubMed ID: 30322390
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
[TBL] [Abstract][Full Text] [Related]
15. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
Okajima K; Harada N; Uchiba M; Isobe H
J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
[TBL] [Abstract][Full Text] [Related]
17. A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.
Seifert HA; Hall AA; Chapman CB; Collier LA; Willing AE; Pennypacker KR
J Neuroimmune Pharmacol; 2012 Dec; 7(4):1017-24. PubMed ID: 23054371
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of catecholamines on function of the rat right heart.
Irlbeck M; Zimmer HG
Cardiovasc Res; 1993 Dec; 27(12):2146-51. PubMed ID: 7906201
[TBL] [Abstract][Full Text] [Related]
20. Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression.
Yan FL; Zhang JH
Med Sci Monit; 2014 Dec; 20():2489-96. PubMed ID: 25434807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
